- Home
- DRH vs IRON Comparison
DRH vs IRON Comparison
Compare DRH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRH
- IRON
- Stock Information
- Founded
- DRH 2004
- IRON 2017
- Country
- DRH United States
- IRON United States
- Employees
- DRH N/A
- IRON N/A
- Industry
- DRH Real Estate Investment Trusts
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- DRH Real Estate
- IRON Health Care
- Exchange
- DRH Nasdaq
- IRON Nasdaq
- Market Cap
- DRH 1.7B
- IRON 1.9B
- IPO Year
- DRH 2005
- IRON N/A
- Fundamental
- Price
- DRH $7.89
- IRON $48.53
- Analyst Decision
- DRH Hold
- IRON Strong Buy
- Analyst Count
- DRH 5
- IRON 10
- Target Price
- DRH $10.05
- IRON $83.80
- AVG Volume (30 Days)
- DRH 2.7M
- IRON 408.9K
- Earning Date
- DRH 05-01-2025
- IRON 05-08-2025
- Dividend Yield
- DRH 4.71%
- IRON N/A
- EPS Growth
- DRH N/A
- IRON N/A
- EPS
- DRH 0.18
- IRON N/A
- Revenue
- DRH $1,129,883,000.00
- IRON N/A
- Revenue This Year
- DRH $2.40
- IRON N/A
- Revenue Next Year
- DRH $2.94
- IRON N/A
- P/E Ratio
- DRH $43.64
- IRON N/A
- Revenue Growth
- DRH 5.12
- IRON N/A
- 52 Week Low
- DRH $7.54
- IRON $25.64
- 52 Week High
- DRH $10.00
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- DRH 44.86
- IRON 35.17
- Support Level
- DRH $7.54
- IRON $51.57
- Resistance Level
- DRH $8.04
- IRON $53.61
- Average True Range (ATR)
- DRH 0.18
- IRON 2.16
- MACD
- DRH 0.01
- IRON -0.42
- Stochastic Oscillator
- DRH 62.73
- IRON 24.72
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.